Cargando…

Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study

Detalles Bibliográficos
Autores principales:	Borgonovo, Fabio, Passerini, Matteo, Piscaglia, Marco, Morena, Valentina, Giacomelli, Andrea, Oreni, Letizia, Dedivitiis, Gianfranco, Lupo, Angelica, Falvella, Stefania, Cossu, Maria Vittoria, Capetti, Amedeo F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857121/ https://www.ncbi.nlm.nih.gov/pubmed/33545166 http://dx.doi.org/10.1016/j.jinf.2021.01.023

Ejemplares similares

Short‐term inhibition of SARS‐CoV‐2 by hydrogen peroxide in persistent nasopharyngeal carriers
por: Capetti, Amedeo F., et al.
Publicado: (2020)

Persistence of Long-COVID symptoms in a heterogenous prospective cohort
por: Mariani, Chiara, et al.
Publicado: (2022)

One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG
por: Capetti, Amedeo F., et al.
Publicado: (2021)

Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects
por: Borgonovo, Fabio, et al.
Publicado: (2022)

Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems
por: Melzi, Sara, et al.
Publicado: (2010)

Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy
por: Giacomelli, Andrea, et al.
Publicado: (2018)

Strategic use of dual regimens of boosted protease inhibitors plus maraviroc in poorly adherent subjects in view of long-acting drugs: A retrospective study
por: Capetti, Amedeo Ferdinando, et al.
Publicado: (2017)

Mortality among Italians and immigrants with COVID-19 hospitalised in Milan, Italy: data from the Luigi Sacco Hospital registry
por: Giacomelli, Andrea, et al.
Publicado: (2022)

Durability of INI-containing regimens after switching from PI-containing regimens: a single-centre cohort of drug-experienced HIV-infected subjects
por: Giacomelli, Andrea, et al.
Publicado: (2019)

Disseminated Cryptococcosis in a Patient With Metastatic Prostate Cancer Who Died in the Coronavirus Disease 2019 (COVID-19) Outbreak
por: Passerini, Matteo, et al.
Publicado: (2020)

Clinical and genetic determinants of nevirapine plasma trough concentration
por: Giacomelli, Andrea, et al.
Publicado: (2018)

Is Dolutegravir Plus Atazanavir Overburdened With Concentration-Related Neurological Events Compared With Other Dual Regimens?
por: Capetti, Amedeo F, et al.
Publicado: (2019)

Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers
por: Cossu, Maria Vittoria, et al.
Publicado: (2014)

Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine.
por: Pezzati, Laura, et al.
Publicado: (2021)

Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients
por: Salvaggio, S. E., et al.
Publicado: (2017)

Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort
por: Ciccullo, Arturo, et al.
Publicado: (2022)

Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort study
por: Giacomelli, Andrea, et al.
Publicado: (2021)

Trend in the proportion of subjects with SARS-CoV-2 infection without COVID-19 specific symptoms among patients admitted to a COVID-19 referral hospital
por: Giacomelli, Andrea, et al.
Publicado: (2023)

Evolution of the SARS-CoV-2 epidemic: From genomic surveillance to new health needs
por: Giacomelli, Andrea, et al.
Publicado: (2023)

Risks of potential drug–drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience
por: Cattaneo, D., et al.
Publicado: (2021)

30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study
por: Giacomelli, Andrea, et al.
Publicado: (2020)

Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?
por: Antinori, Spinello, et al.
Publicado: (2020)

Low influenza vaccination coverage among hospitalized COVID-19 patients in Milan: A gap to be urgently filled
por: Ridolfo, Anna Lisa, et al.
Publicado: (2021)

Factors involved in treatment durability and immunological recovery in a cohort of HIV-positive patients receiving atazanavir-based regimens
por: Giacomelli, Andrea, et al.
Publicado: (2014)

Estimating the effectiveness of remdesivir on risk of COVID-19 mortality: The role of observational data
por: Giacomelli, Andrea, et al.
Publicado: (2022)

Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study
por: Bonazzetti, Cecilia, et al.
Publicado: (2022)

Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy
por: Morena, Valentina, et al.
Publicado: (2020)

Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort
por: Capetti, Amedeo F., et al.
Publicado: (2016)

Consumption of antibiotics at an Italian university hospital during the early months of the COVID-19 pandemic: Were all antibiotic prescriptions appropriate?
por: Giacomelli, Andrea, et al.
Publicado: (2021)

Drug–Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients
por: Cattaneo, Dario, et al.
Publicado: (2021)

Mortality rates among COVID-19 patients hospitalised during the first three waves of the epidemic in Milan, Italy: A prospective observational study
por: Giacomelli, Andrea, et al.
Publicado: (2022)

LightSNiP assay is a good strategy for pharmacogenetics test
por: Cheli, Stefania, et al.
Publicado: (2015)

Duration of Purkinje cell complex spikes increases with their firing frequency
por: Warnaar, Pascal, et al.
Publicado: (2015)

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data
por: Capetti, Amedeo F., et al.
Publicado: (2017)

Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE)
por: Ciccullo, Arturo, et al.
Publicado: (2019)

ECT INDUCED EEG SEIZURE: VALIDITY OF DURATION ESTIMATION BY LAST SPIKE
por: Gangadhar, B.N., et al.
Publicado: (1993)

Remdesivir in moderate to severe COVID-19: A matter of time?
por: Bonazzetti, Cecilia, et al.
Publicado: (2021)

Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status
por: Antinori, Spinello, et al.
Publicado: (2020)

Duration of complex-spikes grades Purkinje cell plasticity and cerebellar motor learning
por: Yang, Yan, et al.
Publicado: (2014)

Drug–Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy
por: Cattaneo, Dario, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_guksqev946l07ggqjopvbklsjp